The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 9,401–9,500 of 31,469
Wu, K. L. H., Chao, Y., Tsay, S.-J., Chen, C. H., Chan, S. H. H., Dovinová, I., & Chan, J. Y. H. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03777 · Cited by 38
Canivell, S., Ruano, E. G., Sisó‐Almirall, A., Kostov, B., Paz, L. G., Fernández‐Rebollo, E., Hanzu, F. A., Párrizas, M., Novials, A., & Gomis, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099310 · Cited by 41
Egert, S., Fobker, M., Andersen, G., Somoza, V., Erbersdobler, H. F., & Wahrburg, U. (2008) · Annals of Nutrition and Metabolism · doi:10.1159/000172980 · Cited by 38
Wu, Y., Tseng, P., Lee, Y., Wang, S.-Y., Chiu, H., Tu, C., Wang, H., Lin, J., Wu, M., & Yang, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092001 · Cited by 38
Hirsch, F. F., Pareja, J. C., Geloneze, S. R., Chaim, É. A., Cazzo, E., & Geloneze, B. (2012) · Obesity Surgery · doi:10.1007/s11695-012-0589-0 · Cited by 38
Siegel, A. B., Goyal, A., Salomao, M. A., Wang, S., Lee, V., Hsu, C. C.-S., Rodriguez, R., Hershman, D. L., Brown, R. S., Neugut, A. I., et al. (2014) · Oncology · doi:10.1159/000367971 · Cited by 38
Krebs, J. D., Parry‐Strong, A., Weatherall, M., Carroll, R. W., & Downie, M. R. (2012) · Metabolism · doi:10.1016/j.metabol.2012.01.021 · Cited by 39
He, J., Yang, Z., Yang, H., Wang, L., Wu, H.-L., Fan, Y., Wang, W., Fan, X., & Li, X. (2015) · Peptides · doi:10.1016/j.peptides.2014.12.012 · Cited by 38
Lifestyle Intervention Improves Fitness Independent of Metformin in Obese Adolescents
Rynders, C. A., WELTMAN, A. L., DelGiorno, C., Balagopal, P., Damaso, L. C., Killen, K., & Mauras, N. (2011) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31823cef5e · Cited by 38
Hwang, Y., Ahn, H. Y., Park, H., & Park, C. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0587-x · Cited by 38
The Effect of Stevia Rebaudiana on Serum Omentin and Visfatin Level in STZ-Induced Diabetic Rats
Akbarzadeh, S., Eskandari, F., Tangestani, H., Bagherinejad, S. T., Bargahi, A., بزی, پ., Daneshi, A., Sahrapoor, A., O'Connor, W. J., & Rahbar, A. R. (2014) · Journal of Dietary Supplements · doi:10.3109/19390211.2014.901999 · Cited by 41
Taurine Alleviates the Progression of Diabetic Nephropathy in Type 2 Diabetic Rat Model
Koh, J. H., Lee, E. S., Hyun, M., et al. (2014) · International Journal of Endocrinology · doi:10.1155/2014/397307 · Cited by 38
Kim, M.-K., Suk, J. H., Kwon, M. J., Chung, H. S., Yoon, C. S., Jun, H. J., Ko, J. H., Kim, T. K., Lee, S. H., Oh, M. K., et al. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.01.022 · Cited by 39
Adolescent dietary intakes predict cardiometabolic risk clustering
Moore, L. L., Singer, M. R., Bradlee, M. L., & Daniels, S. R. (2015) · European Journal of Nutrition · doi:10.1007/s00394-015-0863-8 · Cited by 38
Ouwens, D. M., Bekaert, M., Lapauw, B., Nieuwenhove, Y. V., Lehr, S., Hartwig, S., Calders, P., Kaufman, J., Sell, H., Eckel, J., et al. (2012) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2012.654800 · Cited by 38
Jia, D., Taguchi, M., & Otsuki, M. (2005) · Metabolism · doi:10.1016/j.metabol.2004.12.005 · Cited by 38
Cătoi, A. F., Suciu, S., Pârvu, A. E., Copăescu, C., Galea, R. F., Buzoianu, A. D., Vereșiu, I. A., CĂTOI, C., & Pop, I. (2014) · Medicine and Pharmacy Reports · doi:10.15386/cjm.2014.8872.871.afc1 · Cited by 37
Tsunoda, T., Nozue, T., Yamada, M., Mizuguchi, I., Sasaki, M., & Michishita, I. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.12.026 · Cited by 38
Vasques, A. C. J., Rosado, L. E. F. P. D. L., Rosado, G. P., Ribeiro, R. D. C. L., Franceschini, S. D. C. C., Geloneze, B., Priore, S. E., & de Oliveira, D. R. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000100011 · Cited by 38
Serum visfatin concentrations in gestational diabetes mellitus and normal pregnancy
Rezvan, N., Hosseinzadeh‐Attar, M. J., Masoudkabir, F., Moini, A., Janani, L., & Mazaherioun, M. (2011) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-011-2156-7 · Cited by 39
Quality management for the collection of biological samples in multicentre studies
Peplies, J., Fraterman, A., Scott, R., Russo, P., & Bammann, K. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9481-1 · Cited by 38
Eter, E. A. E., Al‐Masri, A. A., Habib, S., Zamil, H. A., Hersi, A., Hussein, F. A., & Omran, M. A. (2013) · Cell Stress and Chaperones · doi:10.1007/s12192-013-0442-y · Cited by 40
Şengül, C., Çevik, C., Özveren, O., Duman, D., Eroğlu, E., Oduncu, V., Tanboğa, İ. H., Can, M. M., Akgün, T., & Dindar, İ. (2011) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2011.577488 · Cited by 38
Changes in insulin sensitivity and secretion after sleeve gastrectomy
Casella, G., Soricelli, E., Castagneto‐Gissey, L., Redler, A., Basso, N., & Mingrone, G. (2015) · British journal of surgery · doi:10.1002/bjs.10039 · Cited by 38
de Luis, D. A., Conde, R., Sagrado, M. G., Aller, R., Izaola, O., Dueñas, A., Castrillón, J. L. P., & Romero, E. (2010) · PubMed · Cited by 38
Stewart, M. W., Cirkel, D. T., Furuseth, K., Donaldson, J., Biswas, N., Starkie, M., Phenekos, C., & Hamann, A. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01942.x · Cited by 38
Amato, M. C., Guarnotta, V., Forti, D., Donatelli, M., Dolcimascolo, S., & Giordano, C. S. D. S. (2013) · Human Reproduction · doi:10.1093/humrep/det105 · Cited by 39
Adiponectin/leptin ratio and insulin resistance in pregnancy
Skvarča, A., Tomažič, M., Blagus, R., Krhin, B., & Janež, A. (2013) · Journal of International Medical Research · doi:10.1177/0300060513476409 · Cited by 38
Chen, G., Wu, J., Lin, Y.-H., Huang, B., Yao, J. Y., Jiang, Q., Wen, J., & Lin, L. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0710 · Cited by 38
Liu, X., Hamnvik, O. R., Petrou, M., Gong, H., Chamberland, J. P., Christophi, C. A., Kales, S. N., Christiani, D. C., & Mantzoros, C. S. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0660 · Cited by 38
Doğan, Z., Sarıkaya, M., Ergül, B., et al. (2014) · Biomedical Papers · doi:10.5507/bp.2014.036 · Cited by 38
Pérez‐Iglesias, R., de la Foz, V. O., Martínez‐García, O., Amado, J., García‐Unzueta, M. T., Ayesa‐Arriola, R., Suárez‐Pinilla, P., Tabarés‐Seisdedos, R., & Crespo‐Facorro, B. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.07.045 · Cited by 38
Serum concentrations of afamin are elevated in patients with polycystic ovary syndrome
Köninger, A., Edimiris, P., Koch, L., et al. (2014) · Endocrine Connections · doi:10.1530/ec-14-0053 · Cited by 38
Garmendia, M. L., Lera, L., Hugo Sánchez, R., Uauy, R. D., & Cecilia Albala, B. (2009) · Revista médica de Chile · doi:10.4067/s0034-98872009001100001 · Cited by 39
Kim, B. C., Kim, M. K., Han, K., Lee, S.-Y., Lee, S., Ko, S., Kwon, H., Merchant, A. T., Yim, H. W., Lee, W., et al. (2015) · Nutrition Research · doi:10.1016/j.nutres.2015.09.020 · Cited by 38
Biomarkers of Metabolic Syndrome: Biochemical Background and Clinical Significance
Robberecht, H. J., & Hermans, N. (2016) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2015.0113 · Cited by 38
Westergren, H. U., Svedlund, S., Momo, R. A., Blomster, J., Wåhlander, K., Rehnström, E., Greasley, P. J., Fritsche‐Danielson, R., Oscarsson, J., & Gan, L. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0353-1 · Cited by 39
MNK1 and MNK2 mediate adverse effects of high-fat feeding in distinct ways
Moore, C. E., Pickford, J., Cagampang, F. R. A., Stead, R., Tian, S., Zhao, X., Tang, X., Byrne, C. D., & Proud, C. G. (2016) · Scientific Reports · doi:10.1038/srep23476 · Cited by 39
Foote, C. A., Castorena‐Gonzalez, J. A., Ramirez‐Perez, F. I., Jia, G., Hill, M. A., Reyes‐Aldasoro, C. C., Sowers, J. R., & Martinez‐Lemus, L. A. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00285 · Cited by 39
Fuleihan, G. E., Baddoura, R., Habib, R., Halaby, G., Arabi, A., Rahme, M., Singh, R. J., Kassem, M. S., Mahfoud, Z. R., Hoteit, M., et al. (2016) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.132589 · Cited by 39
Leptin as a predictor of metabolic syndrome in prepubertal children
Madeira, I., Bordallo, M. A. N., Rodrigues, N. C. P., et al. (2016) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000199 · Cited by 38
Ye, J.-H., Chao, J., Chang, M., Peng, W., Cheng, H., Liao, J., & Pao, L. (2016) · Scientific Reports · doi:10.1038/srep33102 · Cited by 40
Kamura, Y., Iwata, M., Maeda, S., Shinmura, S., Koshimizu, Y., Honoki, H., Fukuda, K., Ishiki, M., Usui, I., Fukushima, Y., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165523 · Cited by 41
Physical activity and metabolic health in chronic kidney disease: a cross-sectional study
Bowlby, W., Zelnick, L. R., Henry, C., Himmelfarb, J., Kahn, S. E., Kestenbaum, B. R., Robinson‐Cohen, C., Utzschneider, K. M., & de Boer, I. H. (2016) · BMC Nephrology · doi:10.1186/s12882-016-0400-x · Cited by 38
Kim, M. K., Reaven, G. M., & Kim, S. H. (2016) · Obesity · doi:10.1002/oby.21699 · Cited by 39
Karras, S., Persynaki, A., Petróczi, A., Barkans, E., Mulrooney, H., Kypraiou, M., Tzotzas, T., Tziomalos, K., Kotsa, K., Tsioudas, A. A., et al. (2017) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2017.26 · Cited by 37
Kermah, D. A., Shaheen, M., Pan, D., & Friedman, T. (2017) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000324 · Cited by 37
Flaim, C., Kob, M., Pierro, A. M. D., Herrmann, M., & Lucchin, L. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.05.003 · Cited by 38
Ala, O. A., Akintunde, A. A., Ikem, R. T., Kolawole, B. A., Ala, O. O., & Adedeji, T. A. (2017) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2017.06.002 · Cited by 38
Kim, J., Lee, W., Park, S. E., Park, C., Lee, W., Oh, K.-W., Park, S., & Rhee, E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180118 · Cited by 38
Wilner, B. R., Garg, S., Ayers, C. R., Maroules, C. D., McColl, R. W., Matulevicius, S. A., de Lemos, J. A., Drazner, M. H., Peshock, R. M., & Neeland, I. J. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.005897 · Cited by 38
Cetindağlı, I., Kara, M., Tanoğlu, A., Özalper, V., Arıbal, S., Hançerli, Y., Unal, M., Özarı, H. O., Hıra, S., Kaplan, M., et al. (2017) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2017.01.005 · Cited by 38
Yan, Z., Kronemberger, A., Blomme, J., Call, J. A., Caster, H. M., Pereira, R. O., Zhao, H., Melo, V. U. D., Laker, R. C., Zhang, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-08480-2 · Cited by 38
Miele, L., Michele, T. D., Marrone, G., Isgrò, M., Basile, U., Cefalo, C., Biolato, M., Vecchio, F., Rapaccini, G., Gasbarrini, A., et al. (2017) · International Journal of Biological Markers · doi:10.5301/ijbm.5000292 · Cited by 37
Castro-Piñero, J., Delgado-Alfonso, Á., Gracia-Marco, L., Gómez-Martínez, S., Esteban-Cornejo, I., Veiga, Ó., Marcos, A., & Segura-Jiménez, V. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-016048 · Cited by 35
Goh, V. H. H., & Hart, W. G. (2017) · Maturitas · doi:10.1016/j.maturitas.2017.10.002 · Cited by 38
Arner, P., Petrus, P., Estève, D., Boulomié, A., Näslund, E. B., Thorell, A., Gao, H., Dahlman, I. A., & Rydén, M. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0018-0 · Cited by 42
Khedr, S. A., Elmelgy, A. A., El-Kharashi, O. A., Abd-Alkhalek, H. A., Louka, M. L., Sallam, H. A., & Aboul‐Fotouh, S. (2018) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-018-1466-8 · Cited by 38
Metabolic Profiles in Obese Children and Adolescents with Insulin Resistance
Kostovski, M., Simeonovski, V., Mironska, K., Tasic, V. B., & Gucev, Z. S. (2018) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2018.097 · Cited by 39
Lin, J., Sung, K., Su, C., Chou, T.-H., Lo, C., Tsai, J., Chang, S., Lai, Y., Hu, K., Liu, C., et al. (2018) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.117.007047 · Cited by 39
Adaptive changes in pancreas post Roux‐en‐Y gastric bypass induced weight loss
Lautenbach, A., Wernecke, M., Riedel, N., Veigel, J., Yamamura, J., Keller, S., Jung, R., Busch, P., Mann, O., Knop, F. K., et al. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3025 · Cited by 40
Dalvi, P. S., Yang, S. H., Swain, N., Kim, J., Saha, S., Bourdon, C., Zhang, L., Chami, R., & Bandsma, R. (2018) · PLoS ONE · doi:10.1371/journal.pone.0199916 · Cited by 38
Massera, D., Biggs, M. L., Walker, M. D., Mukamal, K. J., Ix, J. H., Djoussé, L., Valderrábano, R. J., Siscovick, D. S., Tracy, R. P., Xue, X., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0849 · Cited by 38
Giezenaar, C., Luscombe‐Marsh, N. D., Hutchison, A. T., Lange, K. M., Hausken, T., Jones, K. L., Horowitz, M., Chapman, I. M., & Soenen, S. (2018) · Nutrition and Diabetes · doi:10.1038/s41387-018-0048-7 · Cited by 38
Spinal epidural lipomatosis is a previously unrecognized manifestation of metabolic syndrome
Ishihara, S., Fujita, N., Azuma, K., Michikawa, T., Yagi, M., Tsuji, T., Takayama, M., Matsumoto, H., Nakamura, M., Matsumoto, M., et al. (2018) · The Spine Journal · doi:10.1016/j.spinee.2018.07.022 · Cited by 39
Golubić, M., Schneeberger, D. L., Kirkpatrick, K., Bar, J., Bernstein, A., Weems, F., Ehrman, J. P., Perko, J., Doyle, J., & Roizen, M. F. (2018) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2018.0193 · Cited by 38
Retnakaran, R. R., Ye, C., Kramer, C. K., Hanley, A. J., Connelly, P. W., Sermer, M., & Zinman, B. (2018) · Diabetologia · doi:10.1007/s00125-018-4710-3 · Cited by 40
Lower Pretreatment Gut Integrity Is Independently Associated With Fat Gain on Antiretroviral Therapy
Kamari, V. E., Moser, C., Hileman, C. O., Currier, J. S., Brown, T. T., Johnston, L., Hunt, P. W., & McComsey, G. A. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy716 · Cited by 38
Low serum adiponectin is a predictor of progressing to nonalcoholic fatty liver disease
Zhang, H., Niu, Y., Gu, H., Lü, S., Zhang, W., Li, X., YANG, Z. K., Qin, L., & Su, Q. (2018) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.22709 · Cited by 39
Lu, C., Chang, H., Yang, K., Chiang, C., Yao, C., & Huang, K. (2019) · Nutrients · doi:10.3390/nu11020477 · Cited by 38
Associations of statin use with glycaemic traits and incident type 2 diabetes
Ahmadizar, F., Ochoa‐Rosales, C., Glišić, M., Franco, O. H., Muka, T., & Stricker, B. H. C. (2019) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13898 · Cited by 38
Gual‐Grau, A., Guirro, M., Mayneris‐Perxachs, J., Arola, L., & Boqué, N. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.06.005 · Cited by 40
Sun, K., Lin, D., Feng, Q., Feng, L., Qi, Y., Feng, W., Yang, C. H., Yan, L., Ren, M., & Liu, D. (2019) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-019-0450-x · Cited by 38
Goff, L. M., Ladwa, M., Hakim, O., & Bello, O. (2019) · Proceedings of The Nutrition Society · doi:10.1017/s0029665119001034 · Cited by 39
Khoudary, S. R. E., Zhao, Q., Venugopal, V., Manson, J. E., Brooks, M. M., Santoro, N. F., Black, D. M., Harman, S. M., Cedars, M. I., Hopkins, P. N., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012763 · Cited by 38
Wargny, M., Smati, S., Pichelin, M., Bigot‐Corbel, E., Authier, C., Dierry, V., Zaïr, Y., Jacquin, V., Hadjadj, S., Boursier, J., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0221524 · Cited by 38
Boughanem, H., Cabrera-Mulero, A., Millán‐Gómez, M., Garrido‐Sánchez, L., Cardona, F., Tinahones, F. J., Moreno‐Santos, I., & Macías‐González, M. (2019) · Genes · doi:10.3390/genes10090706 · Cited by 38
Vitamin E is an effective treatment for nonalcoholic steatohepatitis in HIV mono-infected patients
Sebastiani, G., Saeed, S., Lebouché, B., de Pokomandy, A., Szabo, J., Haraoui, L., Routy, J., Wong, P. Y. N., Deschênes, M., Ghali, P., et al. (2019) · AIDS · doi:10.1097/qad.0000000000002412 · Cited by 38
Yin, C., Hu, W. M., Wang, M., & Xiao, Y. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0452-6 · Cited by 38
Rancourt, R. C., Ott, R., Ziska, T., Schellong, K., Melchior, K., Henrich, W., & Plagemann, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020479 · Cited by 41
Zhang, Y., Ni, T., Zhang, D., et al. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2019.103774 · Cited by 38
Salman, A., Sultan, A. A. E. A., Abdallah, A., Abdelsalam, A., Mikhail, H. M. S., Tourky, M. S., Omar, M. G., Youssef, A., Ahmed, R. A., Elkassar, H., et al. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15029 · Cited by 38
de Oliveira, D. T., Fernandes, I. D. C., de Sousa, G. G., dos Santos, T. A. P., de Paiva, N. C. N., Carneiro, C. M., Evangelista, E. A., Barboza, N. R., & Guerra‐Sá, R. (2020) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000199 · Cited by 41
Warmink, K., Kozijn, A., Bobeldijk, I., Stoop, R., Weinans, H., & Korthagen, N. (2020) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2020.03.008 · Cited by 36
Racial and ethnic differences in the metabolic response of polycystic ovary syndrome
Ezeh, U. I., Chen, Y.-D. I., & Azziz, R. (2020) · Clinical Endocrinology · doi:10.1111/cen.14193 · Cited by 40
Campanella, A., Iacovazzi, P. A., Misciagna, G., Bonfiglio, C., Mirizzi, A., Franco, I., Bianco, A., Sorino, P., Caruso, M. G., Cisternino, A. M., et al. (2020) · Nutrients · doi:10.3390/nu12061674 · Cited by 38
Nokoff, N., Scarbro, S. L., Moreau, K. L., Zeitler, P. S., Nadeau, K. J., Reirden, D. H., Juarez‐Colunga, E., & Kelsey, M. M. (2020) · Transgender Health · doi:10.1089/trgh.2020.0029 · Cited by 38
Lischka, J., Schanzer, A., Hojreh, A., Ssalamah, A. B., Item, C. B., de Gier, C., Walleczek, N., Metz, T. F., Jakober, I., Greber‐Platzer, S., et al. (2020) · Pediatric Obesity · doi:10.1111/ijpo.12739 · Cited by 38
Miaffo, D., Ntchapda, F., Mahamad, A. T., Maidadi, B., & Kamanyi, A. (2020) · Metabolism Open · doi:10.1016/j.metop.2020.100071 · Cited by 39
Farhan, S., Redfors, B., Maehara, A., McAndrew, T., Ben‐Yehuda, O., Bruyne, B. D., Mehran, R., Vogel, B., Giustino, G., Serruys, P. W. J. C., et al. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01207-0 · Cited by 38
Zhao, L., Ma, P., Peng, Y., Wang, M., Peng, C., Zhang, Y., & Li, X. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153477 · Cited by 39
Zamarrón, E., Oriol, A. J., García‐Sánchez, A., Díaz-Cambriles, T., Alonso‐Fernández, A., Lores, V., Mediano, O., Rodríguez-Rodríguez, P., Cabello, S., Morales, E., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-85023-w · Cited by 38
Association of Obstructive Sleep Apnea with the Aging Process
Pinilla, L., Santamaría-Martos, F., Benitez, I. D., Zapater, A., Targa, A., Mediano, O., Masa, J. F., Masdeu, M. J., Mínguez, O., Aguilà, M., et al. (2021) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202007-771oc · Cited by 42
Yao, L., Wang, X., Zhong, Y., Wang, Y., Wu, J., Geng, J., Zhou, Y., Chen, J., Guan, P., Xu, Y., et al. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s294408 · Cited by 40
Manco, M., Guerrera, S., Ravà, L., Atti, M. L. C. D., Vara, S. D., Valeri, G., & Vicari, S. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01345-3 · Cited by 38
Hassan, R. M., Elsayed, M., Kholief, T., Hassanen, N., Gafer, J., & Attia, Y. A. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-14089-w · Cited by 39
Kempf, E., Vogel, M., Vogel, T., et al. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.100977 · Cited by 38
Abdelhameed, R. F. A., Ibrahim, A. K., Elfaky, M. A., Habib, E. S., Mahamed, M. I., Mehanna, E. T., Darwish, K. M., Khodeer, D. M., Ahmed, S. A., & Elhady, S. S. (2021) · Antioxidants · doi:10.3390/antiox10111713 · Cited by 38
Albalak, G., Stijntjes, M., Wijsman, C. A., Slagboom, P. E., van der Ouderaa, F. J., Mooijaart, S. P., van Heemst, D., & Noordam, R. (2021) · International Journal of Obesity · doi:10.1038/s41366-021-01018-7 · Cited by 39
Gong, P., Wang, X., Liu, M., Wang, M., Wang, S., Guo, Y., Chang, X., Yang, W., Chen, X., & Chen, F. (2022) · Food & Function · doi:10.1039/d1fo03487a · Cited by 38
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
